Medical Advocates
HCV Infection/Disease
  Prevention

General Measures
Immunization






 
HCV Main Page Main New/Newsworthy   Home Page    
Last Update:  September 06, 2010
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Measures
       

     Journal Papers, Abstracts, and Commentaries      

 
Epidemiology, Surveillance, and Prevention of Hepatitis C Virus Infections in
Hemodialysis Patients.
Patel PR, Thompson ND, Kallen AJ, Arduino MJ.
Am J Kidney Dis. 2010 Jun 4
 Abstract

Factors Associated with Prevalent Hepatitis C Infection Among HIV-Infected Women with No
Reported History of Injection Drug Use: The Women's Interagency HIV Study (WIHS).
 Frederick T, Burian P, Terrault N,  et al
AIDS Patient Care STDS. 2009 Oct 30.
 Abstract

The impact of the prevention programme of hepatitis C over more than a decade:
the French experience.
 Delarocque-Astagneau E, Meffre C, Dubois F, et al
J Viral Hepat. 2009 Sep 23
 Abstract

Pilot study of postexposure prophylaxis for hepatitis C virus in healthcare workers.
Corey KE, Servoss JC, Casson DR, et al
 Infect Control Hosp Epidemiol. 2009 Oct;30(10):1000-5.
 Abstract

Effects of a hepatitis C virus educational intervention or a motivational intervention on alcohol use, injection drug use,
and sexual risk behaviors among injection drug users
Zule WA, Costenbader EC, Coomes CM, Wechsberg WM.  
Am J Public Health. 2009 Apr;99 Suppl 1:S180-6.
Abstract
 
Postexposure immunization and prophylaxis of bloodborne pathogens following a traumatic explosive
event: preliminary recommendations.
 Subbarao I, Steinbrecher R, Tan L, et al
Disaster Med Public Health Prep. 2007 Nov;1(2):106-9
 Abstract
 
Hepatitis C meanings and preventive strategies among street-involved young injection drug users
in Montréal.
 Roy E, Nonn E, Haley N, Cox J.  
Int J Drug Policy. 2007 Oct;18(5):397-405.
 Abstract
 
A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus
infection in young injection drug users.
Garfein RS, Golub ET, Greenberg AE, et al 
AIDS. 2007 Sep;21(14):1923-1932.
 Abstract
 
How can hepatitis C be prevented in the long term?
 Mateu-Gelabert P, Treloar C, Calatayud VA, et al
Int J Drug Policy. 2007 Oct;18(5):338-40.
 Abstract
 
Prevention of HCV infection in the hemodialysis setting.
 Lombardi M, Dattolo P, Ferro G, Michelassi S.
 G Ital Nefrol. 2007 May-Jun;24(3):202-11.
 Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
Design and Feasibility of a Randomized Behavioral Intervention to Reduce Distributive Injection
Risk and Improve Health-Care Access Among hepatitis C virus Positive Injection Drug Users:
The Study to Reduce Intravenous Exposures (STRIVE).
Kapadia F, Latka MH, Hagan H, et al
J Urban Health. 2007 Jan 3;
 Abstract
 
FULL-TEXT ARTICLE
 Prophylaxis and follow-up after possible exposure to HIV, hepatitis B
virus, and hepatitis C virus outside hospital: evaluation of policy 2000-3
Sonder GJB, Regez RM, Kees Brinkman K, et al
 BMJ  2005;330:825-829
 Paper

Does bleach disinfection of syringes protect against hepatitis C infection among y
oung adult injection drug users?
Kapadia F, Vlahov D, Des Jarlais DC, et al.
 Epidemiology 2002 Nov;13(6):738-41
 Abstract

  

    Conference Reports, Abstracts, and Posters

  CONFERENCE PRESENTATION
 Prevention of Spread of HCV
 Alter MJ
 NIH Consensus Development Conference on Management of Hepatitis C: 2002]
Report
Immunization
 
     Journal Papers, Abstracts, and Commentaries
 
 
Hepatitis C virus vaccine
 Wakita T.  
 Nippon Rinsho. 2008 Oct;66(10):1961-4
 Abstract
 
Hepatitis vaccination in patients with hepatitis C: practice and validation of codes at a large
veterans administration medical center.
 Hachem CY, Kramer JR, Kanwal F, El-Serag HB.
Aliment Pharmacol Ther. 2008 Aug 8.
 Abstract
 
A WEEK IN REVIEW FEATURED REPORT
Hepatitis C vaccine: supply and demand.
 Strickland GT, El-Kamary SS, Klenerman P, Nicosia A.
Lancet Infect Dis. 2008 Jun;8(6):379-386.
 Abstract

Protection against persistence of hepatitis C.
 Mehta SH, Cox A, Hoover DR, et al.
Lancet 2002 Apr 27;359(9316):1478-83
 Abstract

  

HCV Main Page Main New/Newsworthy   Home Page    

HCV Prevention